يعرض 1 - 10 نتائج من 10 نتيجة بحث عن '"Pasquale F. Innominato"', وقت الاستعلام: 1.08s تنقيح النتائج
  1. 1
    Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France : African women exhibit a mutational spectrum more similar to Asians than to Caucasians

    المؤلفون: Pasquale F. Innominato, Antoinette Lemoine, Raphaël Saffroy, Jean-François Morère, Pierre Validire, Mohamed Bouchahda, Nelly Bosselut, Véronique Dussaule-Duchatelle, André Balaton, Jocelyne Hamelin, Catherine Guettier, Jean Trédaniel, Sophie Masse

    المصدر: Oncotarget

    مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Pediatrics, genotype, EGFR, Ethnic group, NSCLC, medicine.disease_cause, genetic testing, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Genotype, medicine, ERBB2, neoplasms, Genetic testing, medicine.diagnostic_test, business.industry, Incidence (epidemiology), Cancer, medicine.disease, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Adenocarcinoma, Population study, KRAS, business, Research Paper, RC

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1515adbf1eeb9168f26f7701575f963d
    http://wrap.warwick.ac.uk/89664/1/WRAP-impact-country-birth-genetic-Innominato-2017.pdf

    أضف إلى المفضلة
  2. 2
    Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer

    المؤلفون: Mohamed Hebbar, Stéphanie Truant, Sameh Awad, Rosine Guimbaud, Michel Ducreux, Salvatore Tumolo, Denis Smith, Mohamed Bouchahda, Julien Taieb, Denis Castaing, Valérie Boige, Pasquale F. Innominato, Thierry de Baere, Francis Lévi, Philippe Rougier, Abdoulaye Karaboué, Christian Focan, Carlos Carvalho, Jean-François Morère, Céline Lepère, René Adam

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Time Factors, Organoplatinum Compounds, Colorectal cancer, Cetuximab, medicine.disease_cause, 0302 clinical medicine, Hepatic Artery, Antineoplastic Combined Chemotherapy Protocols, Infusions, Intravenous, Fatigue, Liver Neoplasms, Middle Aged, Oxaliplatin, Survival Rate, Treatment Outcome, Fluorouracil, 030220 oncology & carcinogenesis, Adenocarcinoma, Female, KRAS, Colorectal Neoplasms, medicine.drug, Adult, medicine.medical_specialty, Irinotecan, RC0254, 03 medical and health sciences, Internal medicine, medicine, Humans, Infusions, Intra-Arterial, Survival rate, Aged, Proportional Hazards Models, Retrospective Studies, business.industry, medicine.disease, 030104 developmental biology, Logistic Models, Multivariate Analysis, Camptothecin, business

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59c2d7569d13b5d1c678fb896534859a
    http://wrap.warwick.ac.uk/85119/1/WRAP_flaccept_ak_optiliv_ms_er_13june2016_rev1_fl.pdf

    View record at Wiley
    أضف إلى المفضلة
  3. 3
    Impact of early tumor response on prognostic of patients with unresectable liver metastases from wt-KRAS colorectal cancer (LM-CRC) treated with hepatic artery infusion of irinotecan, 5-fluorouracil and oxaliplatin plus intravenous cetuximab after failure of systemic chemotherapy (European Phase II OPTILIV)

    المؤلفون: Salvatore Tumolo, Mohamed Bouchahda, Francis Lévi, Abdoulaye KarabouÃ, Stéphanie Truant, C. N. J. Focan, Sameh Awad, Valérie Boige, Carlos Carvalho, Denis Smith, Philippe Rougier, Céline Lepère, Michel Ducreux, Pasquale F. Innominato, Denis Castaing, Rosine Guimbaud, Mohamed Hebbar, Jean F. Morere, Thierry de Baere, Julien Taieb

    المصدر: Journal of Clinical Oncology. 34:e15036-e15036

    مصطلحات موضوعية: Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, Cetuximab, Colorectal cancer, business.industry, medicine.medical_treatment, Tumor response, medicine.disease_cause, medicine.disease, Oxaliplatin, Irinotecan, stomatognathic diseases, Fluorouracil, Internal medicine, medicine, KRAS, business, neoplasms, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::dcf0789aa0c41eadb9fafaf0ac98c756
    https://doi.org/10.1200/jco.2016.34.15_suppl.e15036

    أضف إلى المفضلة
  4. 4
    Acquired mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis

    المؤلفون: Mohamed Bouchahda, Lee Gorden, Pasquale F. Innominato, Abdoulaye Karaboué, Raphaël Saffroy, Catherine Guettier, Francis Lévi, René Adam

    المساهمون: Chronotherapy Unit and Department of Medical Oncology, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Rythmes Biologiques et Cancers, Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Paul Brousse, Service d'Oncologie Médicale, Department of Biochemistry, Department of Hepatobiliary Surgery, Department of Surgery and Cancer Biology, Vanderbilt University Medical Center [Nashville], Vanderbilt University [Nashville]-Vanderbilt University [Nashville], Department of Pathology

    المصدر: Cancer Chemotherapy and Pharmacology
    Cancer Chemotherapy and Pharmacology, Springer Verlag, 2010, 66 (3), pp.605-609. ⟨10.1007/s00280-010-1298-9⟩

    مصطلحات موضوعية: Oncology, Cancer Research, Pathology, endocrine system diseases, Colorectal cancer, Drug resistance, Metastases, Toxicology, medicine.disease_cause, Metastasis, 0302 clinical medicine, Medicine, Neoplasm, Pharmacology (medical), Neoplasm Metastasis, ComputingMilieux_MISCELLANEOUS, 0303 health sciences, Mutation, Liver Neoplasms, Acquired, Drug Resistance, Multiple, 3. Good health, 030220 oncology & carcinogenesis, Female, KRAS, Colorectal Neoplasms, Adult, medicine.medical_specialty, Antineoplastic Agents, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, Proto-Oncogene Proteins, Internal medicine, Humans, neoplasms, Retrospective Studies, 030304 developmental biology, Pharmacology, business.industry, Cancer, Retrospective cohort study, medicine.disease, digestive system diseases, respiratory tract diseases, Drug Resistance, Neoplasm, ras Proteins, mutation, business, Follow-Up Studies

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c717b9a8c8f8186ac2de2cd73fa2a3b8
    https://hal.archives-ouvertes.fr/hal-00582598/document

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  5. 5
    Constitutive single nucleotide polymorphisms (SNP) assessment for predicting tolerability and efficacy of triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) in patients (pts) with liver metastases from colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228)

    المؤلفون: Raphaël Saffroy, Denis Smith, Marie-Christine Etienne-Grimaldi, Pasquale F. Innominato, C. N. J. Focan, René Adam, Mohamed Bouchahda, Elodie Peyric, Francis Lévi, Gérard Milano, Carlos Carvalho, Abdoulaye Karaboué, Simon Pernot, Michel Ducreux, Antoinette Lemoine, Rosine Guimbaud, Mohamed Hebbar

    المصدر: Journal of Clinical Oncology. 32:3593-3593

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Cetuximab, business.industry, Colorectal cancer, Single-nucleotide polymorphism, medicine.disease_cause, medicine.disease, Gastroenterology, Oxaliplatin, Irinotecan, Oncology, Tolerability, Internal medicine, medicine, SNP, KRAS, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c2d07ec760920ce9209098cc26dedcb6
    https://doi.org/10.1200/jco.2014.32.15_suppl.3593

    أضف إلى المفضلة
  6. 6
    Four-year survival in patients (pts) undergoing liver surgery after neoadjuvant triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) for previously treated and unresectable liver metastases from kras wt colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228)

    المؤلفون: Denis Smith, Céline Lepère, C. N. J. Focan, Carlos Carvalho, Mohamed Bouchahda, Mohamed Hebbar, Michel Ducreux, Philippe Rougier, Abdoulaye Karaboué, Denis Castaing, Francis Lévi, Rosine Guimbaud, Salvatore Tumolo, Valérie Boige, Pasquale F. Innominato, René Adam, Stéphanie Truant

    المصدر: Journal of Clinical Oncology. 32:3589-3589

    مصطلحات موضوعية: Liver surgery, Cancer Research, medicine.medical_specialty, Cetuximab, Colorectal cancer, business.industry, Intravenous chemotherapy, medicine.disease, medicine.disease_cause, Gastroenterology, Artery infusion, Oncology, Internal medicine, medicine, In patient, KRAS, Previously treated, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::dd005271f2303126bd111162826fa935
    https://doi.org/10.1200/jco.2014.32.15_suppl.3589

    أضف إلى المفضلة
  7. 7
    Chronomodulated hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil (5-FU), and oxaliplatin (l-OHP) plus intravenous (iv) cetuximab (Cet) (Chrono-Optiliv) in patients with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) after treatment failure (European Phase II trial NCT 00852228)

    المؤلفون: C. N. J. Focan, Etienne Chatelut, Luana Ricca, René Adam, Denis Castaing, Marie-Christine Etienne-Grimaldi, Sameh Awad, Gilles Paintaud, Abdoulaye Karaboué, Gérard Milano, Jean F. Morere, Mohamed Bouchahda, Francis Lévi, Eric Vibert, Y. Ajavon, Pasquale F. Innominato

    المصدر: Journal of Clinical Oncology. 31:3606-3606

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Cetuximab, business.industry, Colorectal cancer, Salvage therapy, Cancer, medicine.disease_cause, medicine.disease, Gastroenterology, Oxaliplatin, Surgery, Irinotecan, Oncology, Fluorouracil, Internal medicine, medicine, KRAS, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::528bb9227f1749e371a9bbc3ca718c68
    https://doi.org/10.1200/jco.2013.31.15_suppl.3606

    أضف إلى المفضلة
  8. 8
    Hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil, and oxaliplatin plus intravenous cetuximab (Cet) (Optiliv) after failure on one versus two or three chemotherapy protocols in patients (pts) with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) (European phase II clinical trial NCT00852228)

    المؤلفون: Rosine Guimbaud, Mohamed Bouchahda, Francis Lévi, Valérie Boige, Carlos Carvalho, Stéphanie Truant, Mohamed Hebbar, Michel Ducreux, Salvatore Tumolo, Denis Smith, Abdoulaye Karaboué, Francis Kunstlinger, C. N. J. Focan, Denis Castaing, Thierry de Baere, Sameh Awad, Céline Lepère, Pasquale F. Innominato, René Adam, Philippe Rougier

    المصدر: Web of Science

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, Cetuximab, Colorectal cancer, business.industry, medicine.medical_treatment, medicine.disease, medicine.disease_cause, Oxaliplatin, Clinical trial, Irinotecan, Fluorouracil, Internal medicine, medicine, KRAS, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b10e23238859b4889dc88b2a82d567d3
    https://doi.org/10.1200/jco.2013.31.15_suppl.3599

    أضف إلى المفضلة
  9. 9
    Final results of first European phase II trial of intravenous cetuximab (Cet) and hepatic artery infusion of irinotecan, 5-fluorouracil, and oxaliplatin in patients (pts) with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) after systemic treatment failure (OPTILIV, NCT00852228)

    المؤلفون: Carlos Carvalho, Michel Ducreux, Denis Castaing, Philippe Rougier, Céline Lepère, Mohamed Bouchahda, René Adam, Rosine Guimbaud, C. N. J. Focan, Mohamed Hebbar, Thierry de Baere, Salvatore Tumolo, Francis Kunstlinger, Denis Smith, Stéphanie Truant, Francis Lévi, Abdoulaye Karaboué, Y. Ajavon, Valérie Boige, Pasquale F. Innominato

    المصدر: Journal of Clinical Oncology. 31:466-466

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, Cetuximab, Colorectal cancer, business.industry, medicine.medical_treatment, medicine.disease_cause, medicine.disease, Gastroenterology, Oxaliplatin, Irinotecan, Artery infusion, Fluorouracil, Internal medicine, medicine, KRAS, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::63d14abfb15a6a2f431e560d96684521
    https://doi.org/10.1200/jco.2013.31.4_suppl.466

    أضف إلى المفضلة
  10. 10
    First European phase II trial of intravenous (iv) cetuximab (Cet) and hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil and oxaliplatin in patients with unresectable liver metastases from wt KRAS colorectal cancer (CRC) after systemic therapy failure (OPTILIV, NCT00852228)

    المؤلفون: Rosine Guimbaud, Philippe Rougier, René Adam, Abdoulaye Karaboué, Thierry de Baere, Pasquale F. Innominato, C. N. J. Focan, Salvatore Tumolo, Denis Castaing, Francis Lévi, Carlos Carvalho, Céline Lepère, Michel Ducreux, Valérie Boige, Mohamed Bouchahda, Mohamed Hebbar, Y. Ajavon, Laetitia Proux

    المصدر: Journal of Clinical Oncology. 30:3547-3547

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Cetuximab, business.industry, Colorectal cancer, medicine.disease, medicine.disease_cause, Systemic therapy, Oxaliplatin, Irinotecan, Artery infusion, Fluorouracil, Internal medicine, medicine, KRAS, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::736467177d12722ab26c990df4c8ec84
    https://doi.org/10.1200/jco.2012.30.15_suppl.3547

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء